HARVEY CAPITAL MANAGEMENT INC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
HARVEY CAPITAL MANAGEMENT INC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2018$304,000
-80.7%
5,000
-84.5%
0.12%
-80.6%
Q2 2018$1,573,000
-76.7%
32,215
-49.2%
0.62%
-75.3%
Q1 2018$6,744,000
-29.1%
63,475
-60.2%
2.52%
-26.8%
Q4 2017$9,513,000
+38.0%
159,310
-44.5%
3.45%
+23.9%
Q3 2017$6,892,000
+22.3%
287,200
-0.4%
2.78%
+15.2%
Q2 2017$5,635,000
-15.8%
288,250
+1.1%
2.42%
-19.6%
Q1 2017$6,690,000
+59.1%
285,050
-16.8%
3.00%
+53.5%
Q4 2016$4,204,000
-36.0%
342,700
-10.3%
1.96%
-3.4%
Q3 2016$6,567,000
-11.8%
382,250
-26.9%
2.03%
-45.6%
Q2 2016$7,443,000
-2.0%
523,100
-5.3%
3.73%
+1.3%
Q1 2016$7,595,000
-24.7%
552,400
-7.7%
3.68%
-7.6%
Q4 2015$10,083,000
+37.5%
598,400
-10.6%
3.98%
+36.1%
Q3 2015$7,332,000
-0.5%
669,000
+8.0%
2.93%
+17.4%
Q2 2015$7,368,000
+113.5%
619,700
+97.5%
2.49%
+96.5%
Q1 2015$3,451,000
+1.1%
313,800
+42.4%
1.27%
-3.1%
Q4 2014$3,415,000
+27.6%
220,350
-0.6%
1.31%
+24.8%
Q3 2014$2,676,000
-2.0%
221,750
+4.1%
1.05%
+7.4%
Q2 2014$2,730,000
+72.8%
212,950
+63.3%
0.98%
+55.1%
Q1 2014$1,580,000130,4000.63%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2018
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders